The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia
Neonatal hypoxia-ischemia (HI) often causes hypoxic-ischemic encephalopathy (HIE), a neurological condition that can lead to overall disability in newborns. The only treatment available for affected neonates is therapeutic hypothermia; however, cooling is not always effective to prevent the deleteri...
Main Authors: | Gorane Beldarrain, Enrique Hilario, Idoia Lara-Celador, Marc Chillida, Ana Catalan, Antonia Ángeles Álvarez-Diaz, Daniel Alonso-Alconada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/6/1667 |
Similar Items
-
URB447 Is Neuroprotective in Both Male and Female Rats after Neonatal Hypoxia–Ischemia and Enhances Neurogenesis in Females
by: Gorane Beldarrain, et al.
Published: (2024-01-01) -
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
by: Andrea Duranti, et al.
Published: (2022-12-01) -
The endocannabinoid system and stroke: A focused review
by: Bradley Kolb, et al.
Published: (2019-01-01) -
Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention
by: Syed Shahid Habib, et al.
Published: (2017-06-01) -
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
by: Ines Gallego-Landin, et al.
Published: (2021-12-01)